clinical trial · NCT05312853
Evaluating the Diagnostic and Predictive Value of Non-invasive Tests (NITs) on the Progression of Chronic Liver Disease.
Johannes Gutenberg University Mainz·—·not yet recruiting·n = 250
Chronic Liver Disease
brief summary
Primary objective is to study the relevance of non-invasive test (NITs) in predicting disease stage (diagnostic biomarker) and outcome (predictive biomarker) in patients with suspected or established liver disease and cirrhosis.
started
Jan 15, 2024
primary completion
Apr 15, 2034
completion
Dec 31, 2034
last updated
Jan 3, 2024
detailed description
Non-invasive tests (NITs) may complement and even reduce the need for liver biopsy in the diagnosis and follow up care of patients with chronic liver disease (CLD). NITs either include serum biomarkers (direct or indirect) or ultrasound-based tests, including vibration controlled transient elastography (VCTE), or a combination of both incorporated into several surrogate scores.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol